- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
May 12, 2022Robins Kaplan Practice Group, Attorney Recognized in Elite Trial Lawyers Awards
-
May 9, 2022Six Partners Recognized as “IP Stars” by Managing Intellectual Property
-
May 4, 2022Robins Kaplan LLP Relocates Silicon Valley Office
-
May 18, 2022Breakthrough Greater Boston Gala
-
May 20, 2022Massachusetts Black Lawyers Association Gala
-
May 23, 2022IPWatchdog Patent Litigation Masters™ 2022
-
May 5, 2022Antitrust Law As A Tool Against Privacy Abuses
-
First QuarterANDA Litigation Settlements
-
First QuarterNew ANDA Cases
-
May 13, 2022Twitter Looks to Streamline Even As Musk Puts Acquisition “On Hold”
-
May 12, 2022Mixed Inflation Report Drags Stocks (and Cryptos) Still Lower
-
May 11, 2022Peloton Reels from Big Quarterly Losses
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Robins Kaplan Partners Gary Wilson, Tara Sutton, and Munir Meghjee Appointed to Abilify MDL Litigation Leadership
December 22, 2016
On December 16, 2016, Chief Judge M. Casey Rodgers of the U.S. District Court for the Northern District of Florida appointed three Robins Kaplan LLP partners to the leadership team in the Abilify Compulsivity Cases multi-district litigation. Gary Wilson will be Plaintiffs’ Co-Lead Counsel, and a member of the Plaintiffs’ Executive Committee. Tara Sutton is a member of the Joint Settlement Committee and Munir Meghjee is Plaintiffs’ Federal/State Liaison Counsel.
The Abilify Compulsivity cases were consolidated by the Judicial Panel on Multi-District Litigation in October 2016. The litigation involves claims that Abilify distorts the reward-seeking behaviors in patients, causing them to compulsively gamble or engage in other compulsive activities, such as hyper-sexuality, compulsive shopping, and binge eating. In August 2016, FDA ordered that the Abilify label include warnings about these behaviors.
What is Abilify?
Abilify, also known as aripiprazole, is usually prescribed to treat a variety of disorders including schizophrenia, irritability, agitation, depression, and mania. Sometimes, it is prescribed for patients along with an anti-depressant (called a serotonin reuptake inhibitor) for more severe depressive disorders. Abilify was developed and manufactured by Otsuka Pharmaceutical Co., headquartered in Japan, and Bristol-Myers Squibb, headquartered in New York.
Learn More about Abilify.
If you or someone you know has been prescribed Abilify and has developed a compulsive gambling addiction, compulsive eating addiction, compulsive shopping addiction, or compulsive sex addiction, you may have an Abilify claim or an Abilify lawsuit.
At Robins Kaplan LLP, we investigate potential claims on behalf of Abilify patients to see if they may have an Abilify lawsuit case. Our firm includes attorneys experienced in pharmaceutical lawsuits like Abilify. We are careful listeners and your story is important to us. Our on-staff medical advisors are available to answer your questions and listen to your concerns as you determine what to do next. If you think you or a loved one has been injured by Abilify, we are interested in hearing what you have to say.
For a free case evaluation, please call 1.800.553.9910 (toll-free). Our legal nurse consultants are standing by.
Related Professionals
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.